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Introduction {#sec005}
============

HIV surveillance and programming targeting gay and bisexual men, other men who have sex with men and transgender women (MSM/TG) have until recently been neglected in countries with generalised HIV epidemics\[[@pone.0234384.ref001]\]. Over the last ten years, this has begun to change, with increasing funder and policymaker attention paid to the burden of HIV experienced by these populations\[[@pone.0234384.ref002]--[@pone.0234384.ref004]\], including in South Africa's National Strategic Plan for HIV, TB and STI's\[[@pone.0234384.ref005]\]. Over this same period, coverage of antiretroviral treatment (ART) in sub-Saharan Africa has greatly expanded and AIDS-related mortality in general populations has fallen dramatically\[[@pone.0234384.ref006], [@pone.0234384.ref007]\]. Effective treatment to achieve viral suppression also avoids sexual transmission of the virus, including among MSM\[[@pone.0234384.ref008]\], and at the population level, 'Treatment as Prevention' (TasP) has the potential to reduce HIV incidence\[[@pone.0234384.ref009], [@pone.0234384.ref010]\]. Accordingly, UNAIDS set 'care cascade' targets specifying that of all HIV-positive individuals in a given population, 90% should be aware of their status, 90% of those aware should be on antiretroviral treatment (ART) and 90% of those on ART should be virally suppressed by 2020\[[@pone.0234384.ref011]\].

Targets have not yet been reached in South Africa: among all males aged 15 years and above in Gauteng Province, 85% of those HIV-positive were estimated to be aware of their status, 43% on ART and 34% virally suppressed in 2017\[[@pone.0234384.ref012]\]. A modelling study for Johannesburg estimated that among people aged 15 and older living with HIV in 2016, 73% were aware of their status, 45% on ART and 26% virally suppressed\[[@pone.0234384.ref013]\], indicating large gaps between diagnosis and access to treatment. It is possible, however, that the cascade for MSM and transgender populations differs substantially, but to date little empirical population-representative evidence from sub-Saharan Africa has been published to offer insight\[[@pone.0234384.ref014]--[@pone.0234384.ref018]\].

Experiences of violence, harassment, and stigma routinely inhibit MSM/TG's access to healthcare\[[@pone.0234384.ref019], [@pone.0234384.ref020]\]. While same-gender sex is legally protected in South Africa, MSM/TG nevertheless face societal discrimination\[[@pone.0234384.ref021]\]. There is concern that stigma and discrimination toward MSM/TG may pose barriers to prompt diagnosis, linkage to and retention in care, and adherence to ART, leading to worse HIV care outcomes. Stigma might act differentially across the cascade; there could be more pressure to disclose sexual orientation at the point of HIV testing than at the point of treatment initiation or follow-up. A study of MSM and other men attending two 'Health4Men' MSM-friendly clinics in Johannesburg found no evidence for a difference in ART retention after 24 months among men reporting same sex behaviour and those not\[[@pone.0234384.ref022]\], but it is unknown whether the same would be found for clinics not specifically tailoring for the needs of MSM/TG.

Prompt initiation of HIV care necessarily depends upon uptake and frequency of HIV testing, which itself may be inhibited due to stigma. MSM/TG who initially test HIV-negative need to test repeatedly during periods at risk. Men in South Africa test less frequently than women\[[@pone.0234384.ref023]\], while MSM could be further inhibited due to aforementioned healthcare-related stigma. A qualitative study among urban MSM found that HIV testing was often viewed as a one-off requirement\[[@pone.0234384.ref024]\]. While there is historical evidence of low testing rates among South African MSM\[[@pone.0234384.ref025]\], testing appears to have increased between 2008 and 2013, concordant with increasing provision of MSM programming\[[@pone.0234384.ref026]\] and increases in HIV testing amongst men as a whole during this period\[[@pone.0234384.ref027]\]. There is a need now for up-to-date estimates and preferences for HIV testing among MSM/TG.

To inform HIV prevention and care programming, the TRANSFORM study set out to provide population-representative empirical estimates and correlates of the HIV care cascade and viral suppression among HIV-positive MSM/TG, and recency of and preferences for HIV testing among HIV-negative MSM/TG in Johannesburg, and to explore characteristics associated with these outcomes and behaviours.

Methods {#sec006}
=======

Population {#sec007}
----------

Eligibility criteria included being aged 18 years or older; male gender assigned at birth or current male identity; sex with a man in the past 12 months; and resident in Johannesburg.

Sampling and recruitment {#sec008}
------------------------

To obtain representative estimates, we recruited participants using respondent-driven sampling (RDS) \[[@pone.0234384.ref028]\], informed by formative research conducted within the TRANSFORM study. Recruitment proceeded in 'waves' with two coupons valid for two weeks issued to each participant, except when nearing the target sample size when we reduced to one coupon. Participants were reimbursed ZAR 150 for participation in the study and received ZAR 150 for each recruitee.

Data collection {#sec009}
---------------

Recruitment began in April 2017 with four seed participants, with five additional seeds added until September 2017. Following eligibility screening and informed consent, participants privately completed a self-administered survey in English or Zulu using a tablet computer (see S3 Survey instrument of [S3 Data](#pone.0234384.s003){ref-type="supplementary-material"}), had HIV pre-test counselling, physical examination, blood sample collection, gave swabs for STI testing with a research nurse, and received HIV/STI post-test counselling and STI treatment. Participants were given direct referrals for HIV related care or Pre Exposure Prophylaxis (PrEP) access depending on HIV test outcome, and referrals for syndromic STI treatment onsite or at a local government clinic for partners.

### HIV testing and care cascade indicators {#sec010}

Participants gave a blood sample for HIV rapid-testing, ELISA-confirmed if positive (Alere Combo and Advanced Quality HIV tests, back-up Alere Determine), CD4 count and viral load-testing (GeneXpert) if HIV-positive. We considered individuals as virally suppressed if they had \<50 viral copies/ml plasma, in line with current South African treatment guidelines\[[@pone.0234384.ref029]\]. There is also evidence that individuals with viral loads greater than 50 copies/ml plasma but less than 1000 copies/ml show increased likelihood of poor treatment outcomes compared to those with viral load measures less than 50 copies/ml\[[@pone.0234384.ref030]\]. To aid comparison with past studies and those from other settings, we also show the proportion virally suppressed according to cut-offs of \<200 copies/ml, \<400 copies/ml and \<1000 copies/ml in S2 Viral suppression according to different viral load cut-offs of [S2 Data](#pone.0234384.s002){ref-type="supplementary-material"}.

Participants were considered aware of their HIV-positive status if they reported in the self-administered survey ever having tested for HIV and receiving a positive result at their most recent HIV test. Participants reported month and year of most recent HIV test. Assuming tests were conducted on the first of each month, together with interview date we created binary indicators for having tested in the previous three, six and twelve months. Individuals reporting that they had previously tested HIV-positive were asked if they had received care, whether they had "ever started taking ART" and whether they were "currently taking ART".

### Other indicators {#sec011}

Participants reported their age in years, previous month's income, highest educational attainment, employment status, religion, population group (using South African categories), marital status, spouse's gender, neighbourhood of residence and place of birth, their sexual identity, their sex assigned at birth and their current gender identity. We considered participants 'cisgender male' if both sex assigned at birth and current gender were male; 'transfeminine' if sex assigned at birth was male and current identity was female or transgender, 'transmasculine' if sex assigned at birth was female and current identity was male/transgender and 'non-binary' if this was their current gender identity. We used the AUDIT scale\[[@pone.0234384.ref031]\] to assess alcohol use and asked about frequency of use of a variety of recreational drugs, reporting here on use at least once in the past month, excepting tobacco. We used the PHQ-9 scale to assess depressive symptomatology, with cut-off points at 0, 5, 10, 15 and 20 for none, mild, moderate and moderately severe and severe depression, and asked participants whether they openly talked, tried 'very hard' or 'somewhat hard' to hide that that they had sex with men with their friends, family and healthcare workers, or neither spoke openly nor tried to hide it. Participants reported aspects of their sexual behaviour in the previous 3 months separately for male and female partners (if applicable), including number of partners, sexual roles (insertive/receptive anal sex or no anal sex, oral sex with men, and vaginal or anal sex with women), frequency of condom use by role ('always', 'most of the time', 'some of the time', 'rarely', 'never', made binary always/not always), and whether they had given, or had been given money, gifts or favours for sex in the previous 12 months. Participants self-reported experiencing STI symptoms at the time of survey and in the previous 12 months (urethral, genito-urinary or rectal).

For AUDIT and PHQ-9, if participants were missing just one or two responses to the scale of questions, we replaced those missing with the mean of the individual's other responses (mean of questions 1--9 for PHQ9\[[@pone.0234384.ref032]\] and questions 2--8 or 9--10 for AUDIT).

### RDS recruitment diagnostics {#sec012}

As recommended, recruitment was monitored biweekly and assessed against RDS assumptions\[[@pone.0234384.ref033]\]. We describe RDS recruitment in detail in S1 Respondent Driven Sampling recruitment diagnostics of [S1 Data](#pone.0234384.s001){ref-type="supplementary-material"}. Convergence of HIV status, viral suppression and HIV testing in the last 6 months were judged as reasonable when the cumulative RDS-weighted estimate stabilised prior to the full recruitment amongst HIV-positive and negative participants respectively, examined visually.

Statistical analysis {#sec013}
--------------------

RDS-II weighting\[[@pone.0234384.ref034]\] was used to account for sampling design, dropping seed participants (who were purposively selected), and weighting by inverse MSM network size, assuming this was proportional to the probability that they would be given a coupon to participate in the study. Confidence intervals were obtained via bootstrapping.

We described the sociodemographic characteristics of MSM/TG by HIV status, as tested in the study. We examined reported HIV testing behaviour among participants testing HIV-negative in the study, and the care cascade amongst those HIV-positive. We described the proportion of HIV-negative MSM/TG who had ever tested, tested in the last three, six and twelve months, the location of and satisfaction with most recent test, and future testing preferences. We examined the associations between these preferences and age, sexual identity and gender identity characteristics using chi-squared tests with a correction for survey data\[[@pone.0234384.ref035]\]. As the outcome was prevalent, we used RDS-II weighted robust Poisson regression (also dropping seed participants) to obtain weighted prevalence ratios\[[@pone.0234384.ref036], [@pone.0234384.ref037]\] to assess associations between testing in the last 6 months and sociodemographic, sexual behaviour and self-reported STI symptoms, examining first bivariate associations and then adjusting sexual behaviour and STI symptom models for any sociodemographic variables showing evidence for associations with the outcome (Wald test p\<0.2).

The HIV care cascade was constructed by using the RDS-II weighted percentage of all MSM/TG testing HIV-positive in the study who knew their status, were on ART and whose viral load was suppressed, and assessing these against the 90-90-90 targets\[[@pone.0234384.ref011]\]. We described the proportion of HIV-positive MSM/TG who were 'satisfied'/ 'very satisfied' with the privacy and respect they were accorded in their most recent HIV care interaction.

Associations with viral suppression among HIV-positive MSM/TG were also examined using RDS-II weighted robust Poisson regression, as above, first examining sociodemographic characteristics, recreational drug use, depression, disclosure and sexual behaviours adjusted only for age, and then retaining in the adjusted model those characteristics for which the Wald test p value was \<0.2.

Analyses were conducted using the RDS: Respondent-Driven Sampling package version 0.9--2\[[@pone.0234384.ref038]\] and the survey: analysis of complex survey samples package version 3.33--2\[[@pone.0234384.ref039]\] for R version 3.5.1\[[@pone.0234384.ref040]\] and Stata version 12\[[@pone.0234384.ref041]\].

Ethics statement {#sec014}
----------------

This study was approved by the ethics committees at the University of the Witwatersrand, and the London School of Hygiene and Tropical Medicine.

Results {#sec015}
=======

Sociodemographic characteristics of HIV-positive and HIV-negative MSM/TG {#sec016}
------------------------------------------------------------------------

118/300 (37.5%) MSM/TG were HIV-positive and 182/300 were HIV-negative. One seed participant refused HIV testing. Mean age was 26 years, though HIV-positive MSM/TG were older on average than those HIV-negative, [Table 1](#pone.0234384.t001){ref-type="table"}. The majority were born in Johannesburg, had completed secondary education, were Black African, unemployed, Christian and unmarried. While most MSM/TG identified as cisgender male, a substantial minority were transfeminine (15.7% among those HIV-positive and 11.7% among those HIV-negative). HIV-negative MSM/TG more often identified as bisexual, heterosexual or other compared to HIV-positive MSM/TG (40.5% compared to 11.9%).

10.1371/journal.pone.0234384.t001

###### Sociodemographic characteristics of MSM/TG in Johannesburg by HIV status.

![](pone.0234384.t001){#pone.0234384.t001g}

  Sociodemographic Characteristics   HIV-positive, n = 118                        HIV-negative, n = 182                 
  ---------------------------------- -------------------------------------------- ----------------------- ------ ------ ------
  Age in years                       18--21                                       15                      12.8   59     30.6
                                     20--24                                       16                      13.4   51     30.0
                                     25--29                                       36                      27.6   36     19.7
                                     30+                                          51                      46.2   36     19.4
  Place of birth                     Born in Johannesburg                         76                      66.9   105    59.0
                                     Born in South Africa, but not Johannesburg   33                      26.6   65     34.6
                                     Born outside of South Africa                 7                       6.6    11     6.4
                                     Missing                                      2                              1      
  Neighbourhood residence            Soweto                                       66                      58.3   92     53.6
  Braamfontein                       9                                            7.0                     18     7.7    
  Hillbrow                           16                                           15.6                    28     17.1   
  Orange Farm                        7                                            5.4                     6      3.1    
  Other                              20                                           13.7                    38     18.6   
  Religion                           Christianity                                 104                     83.8   155    83.7
                                     Islam                                        3                       2.4    1      1.0
                                     None                                         9                       13.8   26     15.3
                                     Other                                        1                       0.0    0      0.0
                                     Missing                                      0                              1      
  Education completed                Higher Education                             34                      31.2   41     18.2
                                     High School                                  70                      57.4   129    75.6
                                     Junior High                                  12                      9.7    10     5.7
                                     Primary                                      1                       1.7    1      0.3
                                     None                                         0                       0.0    1      0.3
                                     Missing                                      1                              0      
  Employment status                  Employed full-time                           16                      13.3   16     6.1
                                     Employed part-time                           13                      12.5   29     16.5
                                     Self employed                                14                      9.2    19     10.0
                                     Student                                      3                       2.3    16     7.1
                                     Unemployed                                   69                      60.1   98     5.9
                                     Other                                        2                       2.6    4      1.4
                                     Missing                                      0                              1      
  Income per month / ZAR             Under 500                                    33                      28.6   49     27.8
                                     500--999                                     10                      11.1   29     21.6
                                     1000--1999                                   22                      14.5   35     22.5
                                     2000--4999                                   32                      27.3   41     22.6
                                     5000+                                        16                      18.6   14     5.5
                                     Missing                                      5                              14     
  Population group                   Black African                                113                     96.4   173    94.1
                                     Coloured                                     4                       1.9    5      3.4
                                     White                                        0                       0.0    2      0.5
                                     Prefer not to say                            0                       0.0    1      1.0
                                     Other                                        1                       1.7    1      1.0
  Sexual Identity                    Gay or homosexual                            103                     88.1   112    59.6
                                     Bisexual                                     12                      11.7   59     35.3
                                     Heterosexual                                 0                       0.0    3      1.3
                                     Other/Don\'t know                            1                       0.2    8      3.9
                                     Missing                                      2                              0      
  Gender identity                    Cisgender male                               95                      80.6   138    76.9
                                     Transfeminine                                20                      15.7   24     11.7
                                     Transmasculine                               1                       0.3    1      0.3
                                     Non-binary                                   2                       3.4    19     11.2
  Marital Status                     Not married                                  103                     88.2   163    88.4
                                     Married to a man or transgender individual   13                      11.8   17     10.6
                                     Married to a woman                           0                       0.0    2      1.0
                                     Missing                                      2                              0      

n = 1 individual did not consent to HIV testing.

HIV testing behaviours and preferences amongst HIV-negative MSM/TG {#sec017}
------------------------------------------------------------------

24/171 HIV-negative participants reported previous HIV testing but had a missing or partially completed month and year of last HIV test. We did not find statistical evidence for systematic differences between those with and without last HIV test dates (chi-squared tests p\>0.1 for all characteristics shown in [Table 2](#pone.0234384.t002){ref-type="table"} and social network size, with the exception of paying a man in money, gifts or favours in exchange for sex in the last 12 months ('buying sex')). Participants reporting buying sex were more likely to have missing dates for last HIV test, 6/17 compared to 18/153, p = 0.008.

10.1371/journal.pone.0234384.t002

###### Associations with testing for HIV in the previous 6 months among MSM/TG testing HIV-negative in the study.

![](pone.0234384.t002){#pone.0234384.t002g}

  Characteristics of the HIV-negative MSM/TG population   n                                            RDS%     Crude PR   95% CI   p value          
  ------------------------------------------------------- -------------------------------------------- -------- ---------- -------- --------- ------ ---------
  **Sociodemographic Characteristics**                                                                                                               
  Age in years                                            *mean not tested / tested*                   24.5     24.3       1.00     0.97      1.02   0.795
  Born in Johannesburg                                    Born in Johannesburg                         55/93    58.9       1.00                      0.573
                                                          Born in SA, not Johannesburg                 37/53    69.1       1.17     0.87      1.58   
                                                          Born outside of SA                           8/10     61.6       1.05     0.54      2.01   
  Religion                                                None                                         12/24    61.0       1.00                      0.965
                                                          Christianity/Islam/Other                     88/133   61.6       1.01     0.68      1.50   
  Education completed                                     Junior High School                           6/10     65.0       1.06     0.61      1.87   0.973
                                                          High School                                  70/111   61.0       1.00                      
                                                          College/University/Higher Education          24/36    61.3       1.02     0.71      1.46   
  Employment status                                       Unemployed                                   59/88    65.3       1.00                      0.325
                                                          Employed or student                          41/69    55.8       0.85     0.63      1.17   
  Income in the last month                                0--499                                       26/41    55.8       1.00                      0.596
  (ZAR)                                                   500--999                                     13/21    68.8       1.23     0.78      1.94   
                                                          1000--1999                                   19/31    51.4       0.92     0.55      1.56   
                                                          2000--4999                                   27/37    65.9       1.18     0.77      1.82   
                                                          5000+                                        4/14     41.3       0.74     0.32      1.71   
  Sexual Identity                                         Bisexual, heterosexual, other                36/65    60.8       1.00                      0.846
                                                          Gay or homosexual                            64/92    62.0       0.97     0.72      1.31   
  Gender identity                                         Cisgender male                               81/120   64.4       1.00                      0.222
                                                          Transfeminine                                9/19     36.9       0.57     0.30      1.09   
                                                          Transmasculine                               0/1      0.0        \-       \-        \-     
                                                          Non-binary                                   10/17    67.1       1.04     0.68      1.59   
  Marital Status                                          Single/divorced/widowed                      90/141   60.0       1.00                      0.274
                                                          Married to a man or transgender individual   8/12     74.0       1.23     0.85      1.80   
                                                          Married to a woman                           2/2      100.0      \-       \-        \-     
  Neighbourhood                                           Soweto                                       51/83    63.1       1.00                      0.524
                                                          Hillbrow                                     15/19    74.6       1.18     0.81      1.72   
                                                          Braamfontein                                 14/18    66.9       1.06     0.65      1.73   
                                                          Orange Farm                                  4/5      65.1       1.03     0.45      2.35   
                                                          Other[\*](#t002fn005){ref-type="table-fn"}   16/32    44.7       0.71     0.43      1.17   
  **Sexual behaviours**                                                                                                                              
  Sex with a man (3months)                                No                                           19/41    47.0       1.00                      0.083
  Yes                                                     81/116                                       67.6     1.44       0.96     2.16             
  Sex with a woman (3 months)                             No                                           61/94    56.5       1.00                      0.239
  Yes                                                     39/63                                        67.3     1.19       0.89     1.59             
  2+ male partners (3 months)                             No                                           83/131   63.0       1.00                      0.433
  Yes                                                     17/26                                        51.4     0.82       0.49     1.35             
  Sell sex to men (12 months)                             No                                           78/129   55.1       1.00                      \<0.001
  Yes                                                     22/27                                        92.0     1.67       1.36     2.05             
  Buy sex from a man (12 months)                          No                                           91/144   61.1       1.00                      0.313
  Yes                                                     8/11                                         76.1     1.25       0.81     1.91             
  Condomless Anal Intercourse with a man (3 months)       No                                           61/104   58.8       1.00                      0.383
  Yes                                                     39/53                                        67.1     1.14       0.85     1.54             
  Sexual role with men during anal sex, (3 months)        No anal sex with men                         23/45    53.0       0.68     0.45      1.03   0.262
  Receptive anal intercourse                              27/39                                        56.4     0.73       0.47     1.13             
  Insertive anal intercourse                              35/53                                        67.2     0.86       0.61     1.22             
  Versatile                                               15/20                                        77.8     1.00                                 
  Self-reported STI symptoms (12 months)                  No                                           82/123   66.2       1.00                      0.094
  Yes                                                     18/34                                        44.5     0.67       0.42     1.07             

n = 157 HIV-negative with responses to ever tested and date of last test.

n\'s do not add to total where there are some missing responses.

All models exclude seed participants and include weighting for inverse network size (RDS-II).

There was not evidence for associations (Wald test p\<0.2) between sociodemographic characteristics and testing, so we show only univariate associations.

\*Other neighbourhoods include those within Johannesburg with fewer than 10 participants in the study sample.

Few HIV-negative MSM/TG reported never previously HIV testing (10/181, 5.5%), while 100/157, 61.5%, reported having tested in the previous 6 months and 118/157, 73.0% tested in the last 12 months, [Table 3](#pone.0234384.t003){ref-type="table"}.

10.1371/journal.pone.0234384.t003

###### HIV testing history and experiences amongst MSM/TG testing HIV-negative in the study.

![](pone.0234384.t003){#pone.0234384.t003g}

  --------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------- ----------- ------------------------------------------------------ ------------------------------------------------------------ ------- -----------
  **Among all testing HIV-negative, n = 182**                                                                                                                                                                                                                                                                                    
  **Testing history**                                                                                                                     **n/N**                                        **RDS %**                                                                                                                               
  Ever had an HIV test                                                                                                                    171/181                                        94.5                                                                                                                                    
  Had an HIV test in the previous 12 months                                                                                               118/157[\*](#t003fn001){ref-type="table-fn"}   73.0                                                                                                                                    
  Had an HIV test in the past 6 months                                                                                                    100/157[\*](#t003fn001){ref-type="table-fn"}   61.5                                                                                                                                    
  Had an HIV test in the past 3 months                                                                                                    77/157[\*](#t003fn001){ref-type="table-fn"}    49.8                                                                                                                                    
                                                                                                                                                                                                     **\'Satisfied\' or \'Very satisfied\' with privacy**   **\'Satisfied\' or \'Very satisfied\' with respect shown**           
  **Testing preferences**                                                                                                                 **n/N**                                        **RDS %**   **n**                                                  **RDS %**                                                    **n**   **RDS %**
  **Where last tested for HIV, of those ever testing**[\*\*](#t003fn002){ref-type="table-fn"}                                                                                                                                                                                                                                    
  Public hospital or clinic                                                                                                               69/167                                         47.1        68                                                     97.7                                                         66      98.7
  Private hospital or clinic                                                                                                              20/167                                         9.7         19                                                     98.1                                                         19      98.1
  Community HIV testing service for the public                                                                                            41/167                                         24.9        37                                                     92.7                                                         40      99.1
  Community HIV testing service for MSM only                                                                                              25/167                                         13.2        24                                                     95.8                                                         24      95.8
  At home                                                                                                                                 3/167                                          2.4         3                                                      100                                                          3       100
  University/school (write-in response)                                                                                                   7/167                                          2.4         7                                                      100                                                          7       100
  Research study (write-in response)                                                                                                      2/167                                          0.4         2                                                      100                                                          2       100
  ***Amongst those HIV negative and reporting that their last test was negative*, *n = 163***[\*\*\*](#t003fn003){ref-type="table-fn"}:                                                                                                                                                                                          
  **Where would you choose to test in future?**                                                                                                                                                                                                                                                                                  
  Public hospital or clinic                                                                                                               69/162                                         46.9                                                                                                                                    
  Private hospital or clinic                                                                                                              27/162                                         18.3                                                                                                                                    
  Community HIV testing service for the public                                                                                            17/162                                         8.8                                                                                                                                     
  Community HIV testing service for MSM only                                                                                              39/162                                         19.8                                                                                                                                    
  At home                                                                                                                                 10/162                                         6.2                                                                                                                                     
  **Who would you prefer to perform an HIV test in future?**                                                                                                                                                                                                                                                                     
  Doctor or clinical officer                                                                                                              62/162                                         42.1                                                                                                                                    
  Nurse                                                                                                                                   27/162                                         17.0                                                                                                                                    
  Counsellor                                                                                                                              19/162                                         12.4                                                                                                                                    
  MSM community worker                                                                                                                    44/162                                         22.6                                                                                                                                    
  Me (i.e., self-test)                                                                                                                    10/162                                         6.0                                                                                                                                     
  --------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------- ----------- ------------------------------------------------------ ------------------------------------------------------------ ------- -----------

\*n = 24 responses to last HIV test date were missing, n = 1 missing ever tested response.

\*\*n = 5 responses to where last tested were missing.

\*\*\*n = 1 response to where would like to test in future missing.

The most common location for last HIV test was a public clinic or hospital (69/166, 47.1%), followed by a community HIV testing centre for the general public (41/166, 24.8%), while 25/166 (13.2%) had most recently tested at an MSM-specific service. Across all HIV testing locations, MSM/TG reported high levels of satisfaction with the privacy and respect they were shown. The distribution of preferences for future testing venues was diverse and similar to that of last testing location, except for a higher preference for an MSM-specific community testing facility and a private clinic or doctor compared with the percentage who had actually tested in one (19.8% compared to 13.2%, and 18.3% compared to 9.7% respectively). Just under half of participants preferred to test in a public clinic or hospital (46.9%) and preferred to have the test conducted by a doctor/clinician (42.0%), while very few expressed a preference for self-testing (6.0%).

There was little statistical evidence that testing preferences varied by sociodemographic characteristics (full results not shown), with the exception of gender identity (p = 0.006). More transfeminine individuals preferred to test in a public clinic/hospital (18/29, 69.3%) compared to cisgender (62/142, 50.3%) and non-binary (5/18, 22.9%) MSM/TG, while fewer preferred to test at a private clinic (2/29, 10.2%) compared to cisgender (28/142, 19.0%) or non-binary individuals (4/18, 30.5%). There was little difference in the percentages preferring to test in clinics targeted towards MSM by gender identity, though there was no response option given for transgender-tailored clinics.

Associations with having HIV tested in the previous 6 months among HIV-negative MSM/TG {#sec018}
--------------------------------------------------------------------------------------

There was little evidence for associations between sociodemographic characteristics and having HIV tested in the previous 6 months among HIV-negative MSM/TG. Compared to HIV-negative cisgender males, transfeminine individuals were 0.57 times as likely to have tested for HIV in the previous 6 months (95% CI 0.30--1.09), but the statistical evidence for an association between testing and gender identity was not significant overall (p = 0.222).

There was strong evidence that MSM/TG who had exchanged sex for money, gifts or favours in the previous 12 months, 'sold sex', were more likely to have HIV tested in the last 6 months (PR = 1.67, 95% CI 1.36--2.05). There was weak statistical evidence that MSM/TG who had had sex with a man in the previous 3 months were more likely to have tested in the last 6 months compared to those who had not (PR = 1.44, 95% CI 0.96--2.16), and that those who reported experiencing STI symptoms in the past year were less likely to have tested for HIV in the previous 6 months, (PR = 0.67, 95% CI 0.42--1.07).

Viral suppression and engagement in treatment and care among HIV-positive MSM/TG {#sec019}
--------------------------------------------------------------------------------

The percentage of HIV-positive MSM/TG who were virally suppressed (\<50 copies/ml) was estimated to be 46.9% (95% CI 31.5--62.3%, n = 58/118), [Fig 1](#pone.0234384.g001){ref-type="fig"}, [Table 4](#pone.0234384.t004){ref-type="table"}. Self-reported knowledge of HIV-positive status was estimated to be 56.5% (95% CI 40.4--72.6%, n = 76/118) and current ART coverage 30.0% (95% CI 17.1--43.0%, n = 39/118) of all those HIV-positive. Of those who reported currently taking ART, there were 10/39 who were not virally suppressed. There were 29 participants who tested positive for HIV and were virally suppressed but who either did not self-report ever testing positive for HIV, or did not self-report current ART use.

![The HIV care cascade among MSM/TG in Johannesburg, n = 300.](pone.0234384.g001){#pone.0234384.g001}

10.1371/journal.pone.0234384.t004

###### The HIV care cascade among MSM/TG in Johannesburg, n = 300.

![](pone.0234384.t004){#pone.0234384.t004g}

                                                         n                   Unweighted sample %   RDS-II weighted %   95% CI           
  ------------------------------------------------------ ------------------- --------------------- ------------------- -------- ------- --
  **Of All HIV-Positive, n = 118**                                                                                                      
  Knows HIV-Positive Status                              no                  42                                                         
  yes                                                    76                  64.4                  56.5                40.4,    72.6    
  Currently on ART of all HIV-Positive                   no                  79                                                         
  yes                                                    39                  33.1                  30.0                17.1,    43.0    
  Virally suppressed of all HIV-positive                 no: 50+ copies/ml   60                                                         
  yes: \<50 copies/ml                                    58                  49.2                  46.9                31.5,    62.3    
  **Expressed as 90-90-90**                                                                                                             
  Knows HIV-Positive Status                              no                  42                                                         
  yes                                                    76                  64.4                  56.5                40.4,    72.6    
  Currently on ART of those who know they are positive   no                  37                                                         
  yes                                                    39                  51.3                  53.2                32.7,    73.7    
  Virally suppressed of those on ART                     no: 50+ copies/ml   10                                                         
  yes: \<50 copies/ml                                    29                  74.4                  77.3                51.4,    100.0   

Among HIV-positive MSM/TG, 75.6% had last attended HIV care at public clinics and 18.1% at MSM-specific clinics, with the remaining at private clinics. There were 89.3% (n = 63/90) who were satisfied with their last clinic's privacy and 91.5% (n = 65/70) who were satisfied with the respect they were shown; these figures were 100% among those visiting MSM-specific clinics.

Factors associated with viral suppression amongst HIV-positive MSM/TG {#sec020}
---------------------------------------------------------------------

Being virally suppressed was associated in crude analyses with increasing age, PR = 1.03 for each year, 95% CI 0.99--1.06, [Table 5](#pone.0234384.t005){ref-type="table"}. HIV-positive MSM/TG living in Braamfontein, a central neighbourhood, as compared to Soweto, were less likely to be virally suppressed, though the numbers were small (1/9 compared to 39/66, PR = 0.04, 95% CI 0.00--0.33). MSM/TG who were not open with their family about the fact that they had sex with men were less likely to be virally suppressed, though the evidence for the association was weak (PR = 0.72, 95% CI 0.46--1.14). There was evidence that MSM/TG reporting recreational drug use in the last month were more likely to be virally suppressed (PR = 1.56, 95% CI 1.00--2.44). Having paid a man in money, gifts or favours in exchange for sex in the past 12 months was strongly associated with being virally suppressed compared to not buying sex in the last 12 months (PR = 2.16, 95% 1.61--2.89).

10.1371/journal.pone.0234384.t005

###### Associations with viral suppression among HIV-positive MSM/TG.

![](pone.0234384.t005){#pone.0234384.t005g}

  Characteristics of the HIV-positive MSM/TG population                   n                                                              RDS%     Crude PR   95% CI   p value   [\*](#t005fn004){ref-type="table-fn"}aPR   95% CI    p value                 
  ----------------------------------------------------------------------- -------------------------------------------------------------- -------- ---------- -------- --------- ------------------------------------------ --------- --------- ------ ------ -------
  **Sociodemographic characteristics, sexual and gender identity**                                                                                                                                                                                           
  Age in years                                                            *Mean unsuppressed / suppressed*                               28.1     30.2       1.03     0.99      1.06                                       0.130     1.03      1.00   1.06   0.051
  Income per month / ZAR                                                  Under 500                                                      17/33    42.5       1.00                                                          0.869                             
                                                                          500--999                                                       6/10     48.9       1.15     0.48      2.73                                                                         
                                                                          1000--1999                                                     10/22    41.0       0.96     0.43      2.14                                                                         
                                                                          2000--4999                                                     17/32    56.8       1.34     0.72      2.47                                                                         
                                                                          5000+                                                          7/16     51.2       1.20     0.58      2.51                                                                         
  Born in Johannesburg                                                    Born in Johannesburg                                           43/76    47.6       1.00                                                          0.631                             
                                                                          Born in SA, not Johannesburg                                   12/33    43.8       0.92     0.53      1.61                                                                         
                                                                          Born outside of SA                                             3/7      65.2       1.37     0.66      2.87                                                                         
  Religion                                                                None                                                           3/10     24.3       1.00                                                          0.226                             
                                                                          Christianity/Islam/Other                                       55/108   50.7       2.09     0.64      6.81                                                                         
  Education completed                                                     Up to Junior High School                                       8/13     50.0       1.07     0.52      2.20                                       0.985                             
                                                                          High School                                                    32/70    46.9       1.00                                                                                            
                                                                          College/University/HE                                          18/34    47.0       1.00     0.59      1.71                                                                         
  Employment status                                                       Unemployed                                                     33/69    46.0       1.00                                                          0.768                             
                                                                          Employed full-time, part-time, student                         25/48    49.4       1.07     0.67      1.72                                                                         
  Sexual Identity                                                         Gay or homosexual                                              50/103   52.0       1.00                                                          0.738                             
                                                                          Bisexual, heterosexual or other                                7/13     46.3       1.12     0.57      2.20                                                                         
  Gender Identity                                                         Cisgender male                                                 47/95    48.8       1.00                                                          0.477                             
                                                                          Transfeminine                                                  10/20    46.1       0.94     0.52      1.72                                                                         
                                                                          Transmasculine                                                 1/1      100.0      2.05     1.58      2.64                                                                         
                                                                          Non-binary                                                     0/2      0.0                                                                                                        
  Marital Status                                                          Single/divorced/widowed                                        50/103   45.8       1.00                                                          0.515                             
                                                                          Married/civil union/legal to a man or transgender individual   7/13     56.8       1.24     0.65      2.35                                                                         
                                                                          Married to a woman                                             0/0      0          \-       \-        \-                                                                           
  Neighbourhood                                                           Soweto                                                         39/66    55.8       1.00                                                          0.032     1.00                    0.070
                                                                          Hillbrow                                                       6/16     43.2       0.77     0.38      1.58                                       0.67      0.32      1.39          
                                                                          Braamfontein                                                   1/9      2.2        0.04     0.00      0.33                                       0.05      0.01      0.48          
                                                                          Orange Farm                                                    5/7      58.2       1.04     0.44      2.46                                       0.90      0.47      1.71          
                                                                          Other                                                          7/20     31.5       0.56     0.26      1.22                                       0.62      0.29      1.32          
  **Mental health, alcohol and substance use, disclosure of sexuality**                                                                                                                                                                                      
  PHQ9                                                                    None                                                           29/57    47.4       1.00                                                          0.924                             
                                                                          Mild depression                                                10/29    39.1       0.82     0.42      1.61                                                                         
                                                                          Moderate depression                                            11/18    56.7       1.20     0.65      2.20                                                                         
                                                                          Moderately severe or severe depression                         4/8      56.4       1.02     0.38      2.75                                                                         
                                                                          Missing \>2 responses to scale questions                       4/6      45.1       0.95     0.33      2.71                                                                         
  AUDIT                                                                   Low risk drinking                                              28/53    50.2       1.00                                                          0.632                             
                                                                          In excess of low risk drinking guidelines                      19/41    44.7       0.89     0.52      1.54                                                                         
                                                                          Harmful or hazardous drinking                                  4/10     36.0       0.72     0.24      2.11                                                                         
                                                                          Alcohol dependence                                             3/8      24.3       0.48     0.15      1.60                                                                         
                                                                          Missing \>2 responses to scale questions                       4/6      64.3       1.28     0.62      2.65                                                                         
  Use of at least one substance in last month                             No                                                             37/81    39.9       1.00                                                          0.052     1.00                    0.155
  Yes                                                                     21/37                                                          62.4     1.56       1.00     2.44      1.36                                       0.89      2.06                    
  Openly talk about having sex with men with friends                      Yes                                                            38/77    50.5       1.00                                                          0.429                             
  No                                                                      19/40                                                          41.0     0.81       0.48     1.36                                                                                   
  Openly talk about having sex with men with family                       Yes                                                            26/43    58.5       1.00                                                          0.169     1.00                    0.203
  No                                                                      30/72                                                          42.4     0.72       0.46     1.14      0.75                                       0.49      1.16                    
  Openly talk about having sex with men with healthcare workers           Yes                                                            39/77    45.2       1.00                                                          0.704                             
  No                                                                      18/40                                                          49.6     1.10       0.68     1.79                                                                                   
  **Sexual Behaviours**                                                                                                                                                                                                                                      
  Sex with a man (3months)                                                No                                                             5/22     23.8       1.00                                                          0.119     1.00                    0.203
  Yes                                                                     53/96                                                          52.4     2.20       0.82     5.86      1.53                                       0.61      3.86                    
  Sex with a woman (3 months)                                             No                                                             53/107   47.1       1.00                                                          0.941                             
  Yes                                                                     5/11                                                           45.7     0.97       0.44     2.14                                                                                   
  2+ male partners (3 months)                                             No                                                             37/78    47.3       1.00                                                          0.910                             
  Yes                                                                     23/40                                                          45.9     0.97       0.59     1.61                                                                                   
  Sell sex to men (12 months)                                             No                                                             37/78    46.8       1.00                                                          0.860                             
  Yes                                                                     20/37                                                          48.9     1.05       0.63     1.73                                                                                   
  Buy sex from a man (12 months)                                          No                                                             47/102   43.0       1.00                                                          \<0.001   1.00                    0.008
  Yes                                                                     11/14                                                          92.8     2.16       1.61     2.89      1.53                                       1.12      2.08                    
  Condomless Anal Intercourse with a man (3 months)                       No                                                             35/68    51.2       1.00                                                          0.350                             
  Yes                                                                     23/50                                                          40.3     0.79       0.48     1.30                                                                                   
  Sexual role with men during anal sex, (3 months)                        No anal sex with men last 3 months                             5/23     22.8       0.36     0.13      1.01                                       0.239                             
  Receptive anal intercourse                                              26/46                                                          45.7     0.72       0.42     1.24                                                                                   
  Insertive anal intercourse                                              11/20                                                          53.0     0.84       0.46     1.54                                                                                   
  Versatile                                                               13/23                                                          63.2     1.00                                                                                                       

All models exclude seed participants and include weighting for inverse network size (RDS-II).

Adjusted models were adjusted for age and those variables found to be p value \<0.2 in the crude analysis. p values are from Wald tests.

n\'s do not add to total where there are some missing responses.

\*Other neighbourhoods include those within Johannesburg with fewer than 10 participants in the study sample.

In adjusted analyses, the evidence that older MSM/TG were more likely to be virally suppressed remained (aPR = 1.03, 96% CI 1.00--1.06), while the statistical evidence for neighbourhood associations weakened somewhat (p = 0.070). The association between viral suppression and recreational drug use also weakened (aPR = 1.36, 95% CI 0.89--2.06, p = 0.155). Strong evidence that MSM who had bought sex were more likely to virally suppressed remained, though the strength of the association reduced somewhat (aPR = 1.53, 95% CI 1.12--2.08).

Discussion {#sec021}
==========

We estimated a very high HIV prevalence among MSM/TG in Johannesburg, and found half of those HIV-positive to be virally unsuppressed. These findings indicate gaps in the HIV care cascade that represent missed opportunities to improve the health of HIV-positive MSM/TG and to prevent ongoing HIV transmission. Younger MSM/TG who were HIV-positive were less likely to be virally suppressed, emphasising the need for regular and accessible testing and support to engage in HIV care for this group.

We found a higher proportion of MSM/TG to be virally suppressed at 47% (32--62%) than the 34% estimated among all adult males living with HIV in Gauteng in 2017 \[[@pone.0234384.ref012]\], the 26% estimated in Johannesburg in 2016 \[[@pone.0234384.ref013]\] and similar to the 47% (95% CI 43--52%) estimated to be virally suppressed among the HIV-positive adult population in South Africa as a whole in 2017\[[@pone.0234384.ref042]\]. This was the case even with our lower viral load cut-off of 50 copies/ml plasma as compared to 400/ml plasma. Our estimate is also higher than modelled estimates for virological suppression among South African MSM (22%, data from 2013--2015)\[[@pone.0234384.ref043]\]. It is plausible that in addition to challenges related to having sex with men, HIV-positive MSM/TG experience some of the same barriers to achieving viral suppression that men as whole do, as estimates for viral suppression among women are higher than those of men overall (43% compared to 58% nationally among adults\[[@pone.0234384.ref042]\]). Knowledge of status and current ART use among HIV-positive MSM/TG were much higher than that reported amongst MSM in two districts of neighbouring Mpumalanga province in 2012--2013, (56.5% compared to 28.1% and 14.1% aware of status, 30% versus 14% and 10% on ART)\[[@pone.0234384.ref044]\]. Our higher estimates could be related to having an urban sample of MSM/TG and to our more recent data collection. Nonetheless, the percentage of HIV-positive MSM/TG whom we found to be virally suppressed remains well below the UNAIDS target of 73% of all those HIV-positive, indicating gaps in the HIV care cascade. It is encouraging however that HIV-positive MSM/TG receiving HIV care, 76% of whom were attending public clinics and hospitals, reported high levels of satisfaction with the service they received.

We found that HIV-positive MSM/TG who had bought sex from a man in the past 12 months were more likely to be virally suppressed. Our findings could possibly reflect a higher recognition of risk and thus increased care engagement among those buying sex, but we are not able to determine causality. Studies among other MSM/TG populations have found that substance use, alcohol use and mental health are associated with worse care cascade outcomes\[[@pone.0234384.ref045]\], and the fact that we did not find statistically significant associations with these characteristics should be treated with caution. Our sub-sample was small, statistical error remains a possibility and we have not disaggregated different types of drug use.

Almost two thirds of HIV-negative MSM/TG reported having HIV tested within the previous 6 months, higher than among MSM in Soweto in 2008 (28%)\[[@pone.0234384.ref024], [@pone.0234384.ref025]\] and MSM in Mpumalanga in 2014--2015 prior to a testing intervention (38%)\[[@pone.0234384.ref046]\]. Encouragingly, testing was associated with some indicators of higher risk, including selling sex to men, though not self-reported STI symptoms. There remains a need for sustained HIV/STI testing messages. Transfeminine individuals were less likely than cisgender male individuals to have HIV tested, similar to findings from Cape Town\[[@pone.0234384.ref047]\], though the statistical evidence for an association between testing and gender identity was weak; further investigation is needed. Of MSM/TG who did attend HIV testing, it is encouraging that high levels of privacy and respect at last testing experience were reported. That there was not a clear majority preference for testing location and person performing the tests underscores the need for a high volume and variety of accessible and acceptable services for a diverse MSM/TG population. While few MSM/TG reported a preference for HIV self-testing in our study, it is possible that this stems from unfamiliarity: a recent study of MSM in Mpumalanga found high levels of satisfaction with HIV self-testing and increased testing frequency amongst those who had tried it\[[@pone.0234384.ref046]\], though studies from elsewhere have also found that men are reluctant to receive a diagnosis on their own\[[@pone.0234384.ref048]\].

Limitations {#sec022}
===========

Our study set out to obtain population-representative estimate of HIV testing and the care cascade among MSM/TG in Johannesburg, rather than relying upon modelled estimates. While we found that study outcomes of HIV status, viral load and testing and many sociodemographic characteristics showed evidence of converging well, there were some challenges in achieving a representative sample of MSM/TG ([S1 Data](#pone.0234384.s001){ref-type="supplementary-material"}), as in other MSM surveys from the continent\[[@pone.0234384.ref049], [@pone.0234384.ref050]\]. Compared to another study of MSM in Soweto from 2008, we found a lower proportion of MSM/TG who identified as heterosexual or 'straight'\[[@pone.0234384.ref025]\], and our estimates of sexual identity had not converged, S1 Fig A2e of [S1 Data](#pone.0234384.s001){ref-type="supplementary-material"}, likely indicating a difficulty in sampling this group. A higher proportion of participants described themselves as Black African compared to the population of Johannesburg overall; recruitment chains originating from White seeds did not achieve more than two sample waves and White and Asian individuals were not recruited by others. Most participants were recruited from four of the nine seeds.

Following stratification by HIV status, we might have had limited power for investigating factors that are associated with viral suppression among HIV-positive MSM/TG or recent HIV testing among HIV-Negative MSM/TG.

A further limitation was our reliance upon self-reported measures of HIV testing/status awareness and ART use. That half of MSM/TG verified to be virally suppressed did not report currently taking ART and/or did not report being aware of their status suggests that diagnosis and current ART use were under-reported among men testing HIV-positive in our study, discrepancies that we are investigating further\[[@pone.0234384.ref051]\]. Other surveys and studies using self-reported care cascade indicators have also pointed out this problem\[[@pone.0234384.ref052]--[@pone.0234384.ref056]\], with social desirability biases and survey misunderstandings posited as possible explanations. Confusion from care interactions have also been reported in South Africa\[[@pone.0234384.ref057]\]. Misinterpretations about the distinction between 'undetectable' viral load and 'negative' HIV status in provider interactions may represent an increasingly importance source of misclassification that should be investigated further. While our estimate of viral suppression is biologically ascertained, these reporting biases limit our ability to guide programming in identifying whether the gaps in diagnosis versus initiation and retention on ART are most significant.

Conclusions {#sec023}
===========

It is encouraging that MSM/TG do not appear to be lagging in the HIV care cascade compared to the general male population in Johannesburg and are reporting positive care experiences. However, given their higher risks as a group and very high HIV burden, there is a need to continue to focus resources towards further improvement, particularly among younger MSM/TG. A better understanding of sexual mixing and transmission patterns could aid in targeting, development of a differentiated care approach to serve the diversity of MSM would be appropriate, and a dedicated study to understand the needs of the transgender population is warranted.
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Reviewer \#1: No

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This study uses RDS methodology to obtain a representative sample of MSM/TG in Johannesburg, in order to investigate: HIV prevalence, HIV testing behaviour in HIV negative individuals and viral suppression in HIV positive individuals. The study found a high prevalence of HIV, that the majority of negative MSM/TG had tested within the last 6 months, and poor viral suppression in PLHIV, although comparable to that of men in South Africa in general.

This is an important study adding to the evidence base attempting to understand HIV in this key population which has been historically neglected in Sub-Saharan Africa.

I believe the manuscript could be improved by addressing the following comments:

1\) Why was a cut-off of 200 used for viral suppression? The cut-off in South African treatment guidelines at the time of the study, as well as National Department of Health programme monitoring, is 400. The other commonly used cut-off at this time (2017) was 1000 (PEPFAR routine reporting; 2017 South African national HIV prevalence, incidence, behaviour and communication survey). In the new guidelines, 50 will be used. It would be more comparable to the other evidence and applicable to the South African setting to use 400 as a cut-off instead.

2\) In South Africa it is known that there is a large group of MSM who identify as straight (example Lane et al. High HIV Prevalence Among Men who have Sex with Men in Soweto South Africa: Results from the Soweto\'s Men\'s Study AIDS Behav (2011) 15:626--634). The RDS methodology does not appear to have penetrated into this group well (not unexpected). I think it is important to mention this in the discussion.

3\) Although the viral suppression rates are similar to those of other men, the rate of viral suppression in men in South Africa is well below that of women. e.g. 2017 South African national HIV prevalence, incidence, behaviour and communication survey: viral suppression in men- 43%; viral suppression in women- 58%. Is it possible that the finding of similar viral suppression in MSM/TG is related to the fact that men in general experience such significant access barriers?

4\) Reference 31: has this manuscript been accepted for publication yet? I do not believe it can be referenced as it stands. From the journal website:

\"Do not cite the following sources in the reference list: Unavailable and unpublished work, including manuscripts that have been submitted but not yet accepted (e.g., "unpublished work," "data not shown"). Instead, include those data as supplementary material or deposit the data in a publicly available database.\"

5\) There are a few minor editing comments:

\- line 103: please change \"18 years plus\" to \"18 years or older\"

\- Table 1, employment status, unemployed- there appears to be an error in the % column

Reviewer \#2: Review: HIV testing, care and viral suppression among men who have sex with men and transgender individuals in Johannesburg, South Africa

A very well written paper of major interest in the field. The authors estimated a very high HIV prevalence among MSM/TG in Johannesburg, and half of those HIV-positive were virally unsuppressed. These findings indicate gaps in the HIV care cascade that represent missed opportunities to improve the health of HIV-positive MSM/TG and to prevent ongoing HIV transmission.

I only have one major concern that requires the author's revision before publication. The authors have conducted univariate and multivariate logistic regression to identify factors associated with HIV-testing in the previous 6 months amongst those HIV-negative; and to identify factors associated with viral suppression amongst those HIV-positive.

While the authors have correctly interpreted the odds ratios (OR). In this population, these binary outcomes (HIV testing, access to care and viral suppression) are common (\>10%), it is often more desirable to estimate a relative risk (RR) or prevalence ratio since there is an increasing differential between the RR and odds ratio with increasing prevalence rates, and there is a tendency for some to interpret ORs as if they are RRs. The authors can estimate the RR in Stata with a log-binomial regression model or should there be convergence issues, apply the Poisson regression model with a robust error variance. A major consideration in public health research is need to communicate study results to a wider non-statistical community i.e. the medical community, general public, and policy makers. Poisson regression with robust variance and log-binomial regression provide correct estimates and are a better alternative for the analysis of this kind of study design with binary outcomes than logistic regression, as the relative risk or prevalence ratio is more interpretable and easier to communicate than the odds ratio.

Please see references below.

1\. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes. Am J Epidemiol 2003; 157(10):940-3.

2\. Zou G. A Modified Poisson Regression Approach to Prospective Studies with Binary Data. Am J Epidemiol 2004; 159(7):702-6.

3\. Sander Greenland , Model-based Estimation of Relative Risks and Other Epidemiologic Measures in Studies of Common Outcomes and in Case-Control Studies, American Journal of Epidemiology 2004;160:301-305

Simba Takuva, MBChB, MSc, DTM&H.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: Yes: Simbarashe Takuva

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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February 28, 2020

Dear Laramie,

Please find attached our revised manuscript submission.

We thank the editor and reviewers for taking the time to read and make suggestions to improve our manuscript. Below, we respond to editor and reviewer comments, and explain why it is not possible to make data publicly available but give guidance on how researchers can obtain the data upon request.

Yours sincerely,

Elizabeth Fearon

Editor Comments

I invite you to revise and resubmit your manuscript. Please attend to the reviewer\'s comments, which I believe may help to better strengthen the contributions of this manuscript to the field and public health practice. In addition, please attend to the following issues I noted in my review of the manuscript:

1\. If citation 31 is published then please include a brief statement that reviews the RDS recruitment process (methods) and challenges reaching a representative sample using RDS (discussion). It is not enough to just point the reader to a subsequent manuscript. If this paper remains unpublished by the time of your re-submission, please provide sufficient detail on the RDS method and appropriate data on the representativeness of the sample recruited.

RESPONSE: We have now included the more extensive set of RDS diagnostics in Appendix 1 and more detail as to the representativeness of the survey to the discussion of study limitations, p.24.

2\. Please indicate the variables missing data in Table 1 as done in Table 2 in the foot note

RESPONSE: We had added the numbers missing responses for each variable to Table 1.

3\. Please include the test statistics for comparison of recent HIV tests with and without missing date information in text. It is OK that these data are not presented in any of the tables.

RESPONSE: We have added the test statistics to the text, p.12.

I join the reviewers in their enthusiasm for the data you present on an important, but understudied population; highlighting both areas where some successes have been achieved and areas in need of targeted intervention efforts. Please provide a point by point response to each reviewers\' response, and indicate in the response how it was addressed. This will help to facilitate a more timely review.

RESPONSE: Thank you, we respond to each comment and indicate where we have made changes to the manuscript.

Reviewer \#1: This study uses RDS methodology to obtain a representative sample of MSM/TG in Johannesburg, in order to investigate: HIV prevalence, HIV testing behaviour in HIV negative individuals and viral suppression in HIV positive individuals. The study found a high prevalence of HIV, that the majority of negative MSM/TG had tested within the last 6 months, and poor viral suppression in PLHIV, although comparable to that of men in South Africa in general.

This is an important study adding to the evidence base attempting to understand HIV in this key population which has been historically neglected in Sub-Saharan Africa.

RESPONSE: Thank you.

I believe the manuscript could be improved by addressing the following comments:

1\) Why was a cut-off of 200 used for viral suppression? The cut-off in South African treatment guidelines at the time of the study, as well as National Department of Health programme monitoring, is 400. The other commonly used cut-off at this time (2017) was 1000 (PEPFAR routine reporting; 2017 South African national HIV prevalence, incidence, behaviour and communication survey). In the new guidelines, 50 will be used. It would be more comparable to the other evidence and applicable to the South African setting to use 400 as a cut-off instead.

RESPONSE: In the absence of consistent viral load cut-points across studies and contexts, we chose to use 200 viral copies/ml as the cut-off, following CDC recommendations given in:

Centers for Disease Control and Prevention. Questions and Answers for the General Public: Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health Care Settings. However, we agree with the reviewer that it would be helpful to present cascade findings using the South African guidelines. We think it makes most sense to use the cut-off of 50 viral copies/ml plasma to indicate viral suppression (our cut-off for detection was 40 copies/ml) in line with the 2019 South African guidelines, and because there is evidence that those with viral loads \>50 copies/ml but less \< 1000 copies/ml have poorer treatment outcomes compared to those with viral load \<50 copies/ml (Hermans LE, Moorhouse M, Carmona S, Grobbee DE, Hofstra LM, Richman DD, et al. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2018;18(2):188-97).

We have also included in Appendix 2 the viral suppression n's and RDS-weighted %'s for other cut-offs (200, 400 and 1000 copies/ml) used in the past and elsewhere in the literature, in order to aid comparison.

2\) In South Africa it is known that there is a large group of MSM who identify as straight (example Lane et al. High HIV Prevalence Among Men who have Sex with Men in Soweto South Africa: Results from the Soweto\'s Men\'s Study AIDS Behav (2011) 15:626--634). The RDS methodology does not appear to have penetrated into this group well (not unexpected). I think it is important to mention this in the discussion.

RESPONSE: We have added a note to the discussion of study limitations as follows, line 365: "Compared to another study of MSM in Soweto from 2008, we found a lower proportion of MSM who identified as heterosexual or 'straight'(24), possibly indicating a difficulty in sampling this group."

3\) Although the viral suppression rates are similar to those of other men, the rate of viral suppression in men in South Africa is well below that of women. e.g. 2017 South African national HIV prevalence, incidence, behaviour and communication survey: viral suppression in men- 43%; viral suppression in women- 58%. Is it possible that the finding of similar viral suppression in MSM/TG is related to the fact that men in general experience such significant access barriers?

RESPONSE: Yes, we agree this is a possibility and we have now mentioned this in the discussion (see line 315):

"It is plausible that in addition to challenges related to having sex with men, HIV-positive MSM/TG experience some of the same barriers to achieving viral suppression that men as whole do, as estimates for viral suppression among women are higher at than those of men overall (43% compare to 58% nationally among adults(40))."

4\) Reference 31: has this manuscript been accepted for publication yet? I do not believe it can be referenced as it stands. From the journal website:

\"Do not cite the following sources in the reference list: Unavailable and unpublished work, including manuscripts that have been submitted but not yet accepted (e.g., "unpublished work," "data not shown"). Instead, include those data as supplementary material or deposit the data in a publicly available database.\"

RESPONSE: We have now added more detailed RDS diagnostics to Appendix 1 instead of referencing this unpublished manuscript, and have added further detail to the Discussion.

5\) There are a few minor editing comments:

\- line 103: please change \"18 years plus\" to \"18 years or older\"

\- Table 1, employment status, unemployed- there appears to be an error in the % column

RESPONSE: Thank you for bringing these issues to our attention. We have rectified them.

Reviewer \#2: Review: HIV testing, care and viral suppression among men who have sex with men and transgender individuals in Johannesburg, South Africa

A very well written paper of major interest in the field. The authors estimated a very high HIV prevalence among MSM/TG in Johannesburg, and half of those HIV-positive were virally unsuppressed. These findings indicate gaps in the HIV care cascade that represent missed opportunities to improve the health of HIV-positive MSM/TG and to prevent ongoing HIV transmission.

I only have one major concern that requires the author's revision before publication. The authors have conducted univariate and multivariate logistic regression to identify factors associated with HIV-testing in the previous 6 months amongst those HIV-negative; and to identify factors associated with viral suppression amongst those HIV-positive.

While the authors have correctly interpreted the odds ratios (OR). In this population, these binary outcomes (HIV testing, access to care and viral suppression) are common (\>10%), it is often more desirable to estimate a relative risk (RR) or prevalence ratio since there is an increasing differential between the RR and odds ratio with increasing prevalence rates, and there is a tendency for some to interpret ORs as if they are RRs. The authors can estimate the RR in Stata with a log-binomial regression model or should there be convergence issues, apply the Poisson regression model with a robust error variance. A major consideration in public health research is need to communicate study results to a wider non-statistical community i.e. the medical community, general public, and policy makers. Poisson regression with robust variance and log-binomial regression provide correct estimates and are a better alternative for the analysis of this kind of study design with binary outcomes than logistic regression, as the relative risk or prevalence ratio is more interpretable and easier to communicate than the odds ratio.

Please see references below.

1\. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes. Am J Epidemiol 2003; 157(10):940-3.

2\. Zou G. A Modified Poisson Regression Approach to Prospective Studies with Binary Data. Am J Epidemiol 2004; 159(7):702-6.

3\. Sander Greenland , Model-based Estimation of Relative Risks and Other Epidemiologic Measures in Studies of Common Outcomes and in Case-Control Studies, American Journal of Epidemiology 2004;160:301-305

RESPONSE: Thank you for this suggestion. We have re-done our analyses using robust poisson regression to obtain weighted prevalence ratios instead of odds ratios for measure of association (still dropping seed participants and probability weighting using the inverse network weights in line with the RDS design).

Interview Guides

We have added the survey instruments in English and Zulu as supplementary material (S3).

Data Access

Data from this study cannot be deposited publicly because of a high risk of deductive disclosure when reporting all of the information needed to validly analyse the data. This risk is made worse by the vulnerability of the population, which faces social stigma and has reported high levels of harassment, blackmail and abuse in other studies (eg Zahn 2016 (1)) and in our survey.

The data for this study were collected using respondent driven sampling (RDS), a type of peer-referral or 'snowball sampling'. Provided that assumptions are met and appropriate weighting is used, the data can be treated as a probability sample and used to obtain representative estimates of the population, eg HIV status. In practice, these assumptions are hard to meet and it is recommended to examine a set of RDS recruitment dynamics to assess the extent to which the sampling might deviate from assumptions, (see guidance on RDS diagnostics (2)). This requires information about participants' social networks, information about their recruiter and those they recruit, and their position within sampling chains (eg whether one of only nine seed participants). We have given an overview description of the RDS recruitment as an appendix to this manuscript, and one that is specific to this study's primary outcomes. We have taken care to do this while maintaining confidentiality, eg not giving HIV status of seed participants away via showing bottle net plots or recruitment trees by HIV status, but subsequent studies would need the full RDS information to assess the representativeness of the sample with respect to their specific study primary outcomes, eg to produce and examine convergence and bottleneck plots. We are concerned that there is a high risk of deductive disclosure to making the individual-level RDS data public, in combination with data about other characteristics of participants, including highly sensitive HIV and STI testing results and personal characteristics. Even if we removed individual pieces of identifiable information, we are not confident that this would truly anonymise the data.

Although we cannot make study data publicly accessible at the time of publication, all authors commit to make the data underlying the findings of the study available, in compliance with the PLOS Data Availability Policy. Data can be requested via the London School of Hygiene and Tropical Medicine Research Operations Office Data Management Lead: <alex.hollander@lshtm.ac.uk> and the first author (<elizabeth.fearon@lshtm.ac.uk>) and Principal Investigator (<tpalanee@wrhi.ac.za>). Individuals requesting data should give their research objectives and indicate the list of requested variables, see S3 Survey Instrument. For data involving personally identifiable information or other sensitive data, data sharing is contingent on the data being handled appropriately by the data requester and in accordance with all applicable local requirements.

\(1\) Zahn R, Grosso A, Scheibe A, Bekker LG, Ketende S, Dausab F, et al. Human Rights Violations among Men Who Have Sex with Men in Southern Africa: Comparisons between Legal Contexts. PLoS One. 2016;11(1):e0147156

\(2\) Gile KJ, Johnston LG, Salganik MJ. Diagnostics for Respondent-driven Sampling. J R Stat Soc Ser A Stat Soc. 2015;178(1):241-69

Added 26 March, following discussion with editor: for brevity, we propose the following data availability statement:

The data underlying this study cannot be made publicly accessible due to concerns about confidentiality when combining sensitive data about individuals and the respondent driven sampling (RDS) recruitment information needed to reflect the sampling design in analyses.  Although we cannot make study data publicly accessible at the time of publication, all authors commit to make the data underlying the findings of the study available\` in compliance with the PLOS Data Availability Policy. Data can be requested via the London School of Hygiene and Tropical Medicine Research Operations Office Data Management Lead: <alex.hollander@lshtm.ac.uk> and the first author (<elizabeth.fearon@lshtm.ac.uk>) and Principal Investigator (<tpalanee@wrhi.ac.za>). Individuals requesting data should give their research objectives and indicate the list of requested variables, see S3 Survey Instrument. To protect the confidentiality of participants, data sharing is contingent on the data being handled appropriately by the data requester and in accordance with all applicable local requirements.

10.1371/journal.pone.0234384.r003
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**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: (No Response)

Reviewer \#2: Yes
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3\. Has the statistical analysis been performed appropriately and rigorously?
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Reviewer \#2: Yes
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4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.
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Reviewer \#2: Yes
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5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: (No Response)

Reviewer \#2: Yes
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6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: (No Response)

Reviewer \#2: I have no additional comments or edits to add. The authors have attended to all concerns in a satisfactory way. Thank you.
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7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).
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